RVMD
Price:
$41.84
Market Cap:
$6.99B
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RA...[Read more]
Industry
Biotechnology
IPO Date
2020-02-13
Stock Exchange
NASDAQ
Ticker
RVMD
According to Revolution Medicines, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -11.25. This represents a change of 23.25% compared to the average of -9.13 of the last 4 quarters.
The mean historical PE Ratio of Revolution Medicines, Inc. over the last ten years is -20.66. The current -11.25 PE Ratio has changed 5.35% with respect to the historical average. Over the past ten years (40 quarters), RVMD's PE Ratio was at its highest in in the September 2022 quarter at -5.69. The PE Ratio was at its lowest in in the June 2019 quarter at -26.04.
Average
-20.66
Median
-24.38
Minimum
-35.77
Maximum
-7.44
Discovering the peaks and valleys of Revolution Medicines, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 41.83%
Maximum Annual PE Ratio = -7.44
Minimum Annual Increase = -58.18%
Minimum Annual PE Ratio = -35.77
Year | PE Ratio | Change |
---|---|---|
2023 | -7.44 | -3.70% |
2022 | -7.72 | -24.25% |
2021 | -10.19 | -58.18% |
2020 | -24.38 | -31.86% |
2019 | -35.77 | 41.83% |
2018 | -25.22 | -25.51% |
The current PE Ratio of Revolution Medicines, Inc. (RVMD) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.45
5-year avg
-17.10
10-year avg
-20.66
Revolution Medicines, Inc.’s PE Ratio is greater than Blueprint Medicines Corporation (-26.44), less than Sana Biotechnology, Inc. (-4.82), greater than Kymera Therapeutics, Inc. (-21.01), less than Monte Rosa Therapeutics, Inc. (-3.11), less than TCR2 Therapeutics Inc. (-0.44), less than Black Diamond Therapeutics, Inc. (-3.70), less than Atreca, Inc. (-0.04), less than Passage Bio, Inc. (-0.57), less than Akero Therapeutics, Inc. (-8.95), greater than Avidity Biosciences, Inc. (-17.14), less than Protagonist Therapeutics, Inc. (14.97), less than Stoke Therapeutics, Inc. (-7.92), less than Homology Medicines, Inc. (-0.01), less than C4 Therapeutics, Inc. (-3.44), less than Agios Pharmaceuticals, Inc. (-6.74), less than Nurix Therapeutics, Inc. (-8.82),
Company | PE Ratio | Market cap |
---|---|---|
-26.44 | $5.47B | |
-4.82 | $1.12B | |
-21.01 | $2.89B | |
-3.11 | $349.21M | |
-0.44 | $58.11M | |
-3.70 | $305.13M | |
-0.04 | $3.57M | |
-0.57 | $43.48M | |
-8.95 | $1.83B | |
-17.14 | $4.74B | |
14.97 | $2.44B | |
-7.92 | $773.92M | |
-0.01 | $3.02M | |
-3.44 | $374.42M | |
-6.74 | $2.46B | |
-8.82 | $1.50B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revolution Medicines, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Revolution Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Revolution Medicines, Inc.'s PE Ratio?
How is the PE Ratio calculated for Revolution Medicines, Inc. (RVMD)?
What is the highest PE Ratio for Revolution Medicines, Inc. (RVMD)?
What is the 3-year average PE Ratio for Revolution Medicines, Inc. (RVMD)?
What is the 5-year average PE Ratio for Revolution Medicines, Inc. (RVMD)?
How does the current PE Ratio for Revolution Medicines, Inc. (RVMD) compare to its historical average?